Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients
Weinhold, Niels, Salwender, Hans J, Cairns, David A, Raab, Marc S, Waldron, George, Blau, Igor W, Bertsch, Uta, Hielscher, Thomas, Morgan, Gareth J, Jauch, Anna, Davies, Faith E, Hänel, Mathias, Cook, Gordon, Scheid, Christoph, Houlston, Richard, Goldschmidt, Hartmut, Jackson, Graham, Kaiser, Martin F
Published in Haematologica (Roma) (01.10.2021)
Published in Haematologica (Roma) (01.10.2021)
Get full text
Journal Article
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
Mai, Elias K, Huhn, Stefanie, Miah, Kaya, Poos, Alexandra M, Scheid, Christof, Weisel, Katja C, Bertsch, Uta, Munder, Markus, Berlanga, Oscar, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Blau, Igor W, Hänel, Mathias, Salwender, Hans J, Benner, Axel, Raab, Marc S, Goldschmidt, Hartmut, Weinhold, Niels
Published in Blood cancer journal (New York) (04.01.2023)
Published in Blood cancer journal (New York) (04.01.2023)
Get full text
Journal Article
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Baertsch, Marc-Andrea, Mai, Elias K, Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J, Munder, Markus, Fuhrmann, Stephan, Dührsen, Ulrich, Brossart, Peter, Neben, Kai, Schlenzka, Jana, Kunz, Christina, Raab, Marc S, Hillengaß, Jens, Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Goerner, Martin, Hoffmann, Martin, Lindemann, Hans-Walter, Bernhard, Helga, Blau, Igor W, Scheid, Christof, Besemer, Britta, Weisel, Katja C, Hänel, Mathias, Dürig, Jan, Goldschmidt, Hartmut
Published in Blood cancer journal (New York) (07.01.2021)
Published in Blood cancer journal (New York) (07.01.2021)
Get full text
Journal Article
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Klein, Eva-Maria, Tichy, Diana, Salwender, Hans, Mai, Elias, Duerig, Jan, Weisel, Katja, Benner, Axel, Bertsch, Uta, Akhavanpoor, Mabast, Besemer, Britta, Munder, Markus, Lindemann, Hans-Walter, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Raab, Marc, Blau, Igor, Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut
Published in Cancers (28.09.2021)
Published in Cancers (28.09.2021)
Get full text
Journal Article
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial
Goldschmidt, Hartmut, Mai, Elias K, Dürig, Jan, Scheid, Christof, Weisel, Katja C, Kunz, Christina, Bertsch, Uta, Hielscher, Thomas, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Tichy, Diana, Giesen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S, Blau, Igor W, Hänel, Mathias, Salwender, Hans J
Published in Leukemia (01.07.2020)
Published in Leukemia (01.07.2020)
Get full text
Journal Article
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients
Mai, Elias K, Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J, Zweegman, Sonja, Raab, Marc S, Munder, Markus, Pantani, Lucia, Mancuso, Katia, Brossart, Peter, Beksac, Meral, Blau, Igor W, Dürig, Jan, Besemer, Britta, Fenk, Roland, Reimer, Peter, van der Holt, Bronno, Hänel, Mathias, von Metzler, Ivana, Graeven, Ullrich, Müller-Tidow, Carsten, Boccadoro, Mario, Scheid, Christof, Dimopoulos, Meletios A, Hillengass, Jens, Weisel, Katja C, Cavo, Michele, Sonneveld, Pieter, Goldschmidt, Hartmut
Published in Leukemia (01.03.2024)
Published in Leukemia (01.03.2024)
Get full text
Journal Article
CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Kriegsmann, Katharina, Ton, Gigi Nu Hoang Quy, Awwad, Mohamed H. S., Benner, Axel, Bertsch, Uta, Besemer, Britta, Hänel, Mathias, Fenk, Roland, Munder, Markus, Dürig, Jan, Blau, Igor W., Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M., Kunz, Christian, Hensel, Manfred, Seidel-Glätzer, Andrea, Weisel, Katja C., Salwender, Hans J., Müller-Tidow, Carsten, Raab, Marc S., Goldschmidt, Hartmut, Mai, Elias K., Hundemer, Michael
Published in Leukemia (01.07.2024)
Published in Leukemia (01.07.2024)
Get full text
Journal Article
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Mai, Elias K, Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C, Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S, Blau, Igor W, Hänel, Mathias, Benner, Axel, Salwender, Hans J, Goldschmidt, Hartmut
Published in Leukemia (01.03.2021)
Published in Leukemia (01.03.2021)
Get full text
Journal Article
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Mai, Elias K, Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C, Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S, Blau, Igor W, Hänel, Mathias, Benner, Axel, Salwender, Hans J, Goldschmidt, Hartmut
Published in Leukemia (01.12.2021)
Published in Leukemia (01.12.2021)
Get full text
Journal Article
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma
Mai, Elias K, Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J, Munder, Markus, Gerecke, Christian, Dührsen, Ulrich, Brossart, Peter, Neben, Kai, Hillengass, Jens, Raab, Marc S, Merz, Maximilian, Baertsch, Marc-Andrea, Jauch, Anna, Hose, Dirk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor W, Scheid, Christof, Weisel, Katja C, Goldschmidt, Hartmut
Published in Leukemia (01.01.2019)
Published in Leukemia (01.01.2019)
Get full text
Journal Article
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
Mai, Elias K, Goldschmid, Hartmut, Miah, Kaya, Bertsch, Uta, Besemer, Britta, Hänel, Mathias, Krzykalla, Julia, Fenk, Roland, Schlenzka, Jana, Munder, Markus, Dürig, Jan, Blau, Igor W, Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Kunz, Christina, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M, Kunz, Christian, Hensel, Manfred, Benner, Axel, Seidel-Glätzer, Andrea, Weisel, Katja C, Raab, Marc S, Salwender, Hans J
Published in The Lancet. Haematology (01.02.2024)
Published in The Lancet. Haematology (01.02.2024)
Get more information
Journal Article
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
Kriegsmann, Katharina, Manta, Calin, Schwab, Ricarda, Mai, Elias K., Raab, Marc S., Salwender, Hans J., Fenk, Roland, Besemer, Britta, Dürig, Jan, Schroers, Roland, von Metzler, Ivana, Hänel, Mathias, Mann, Christoph, Asemissen, Anne M., Heilmeier, Bernhard, Bertsch, Uta, Huhn, Stefanie, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Hundemer, Michael
Published in Blood advances (14.02.2023)
Published in Blood advances (14.02.2023)
Get full text
Journal Article
Hu-antibody positive limbic encephalitis in a patient with Hodgkin lymphoma
Hentschke, Suna, Malzfeldt, Ernst, Salwender, Hans J., Braumann, Dietrich, Stang, Axel, Hentschke, Moritz
Published in Leukemia & lymphoma (01.01.2008)
Published in Leukemia & lymphoma (01.01.2008)
Get full text
Journal Article
Bilateral thalamic infarction after reinfusion of DMSO-preserved autologous stem-cells
Hentschke, Suna, Hentschke, Moritz, Hummel, Kornelia, Salwender, Hans J., Braumann, Dietrich, Stang, Axel
Published in Leukemia & lymphoma (01.11.2006)
Published in Leukemia & lymphoma (01.11.2006)
Get full text
Journal Article
P-177: Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma: a multicohort analysis from phase III trials
Mai, Elias, Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Munder, Markus, Brossart, Peter, Blau, Igor W., Raab, Marc, Duerig, Jan, Giesen, Nicola, Besemer, Britta, Fenk, Roland, Wattad, Mohammed, Haenel, Mathias, von Metzler, Ivana, Graeven, Ullrich, Scheid, Christoph, Weisel, Katja, Goldschmidt, Hartmut
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article
A Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Kumar, Shaji, Harrison, Simon J., Cavo, Michele, Rubia, Javier DE.LA, Popat, Rakesh, Gasparetto, Cristina J., Hungria, Vania, Salwender, Hans J., Suzuki, Kenshi, Kim, Inho, Punnoose, Elizabeth, Hong, Wan-Jen, Freise, Kevin J., Sood, Anjla, Jalaluddin, Muhammad, Ross, Jeremy, Ward, James E., Maciag, Paulo, Moreau, Philippe
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials
Mai, Elias K., Baertsch, Marc-A., Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J., Munder, Markus, Fuhrmann, Stephan, Duehrsen, Ulrich, Brossart, Peter, Neben, Kai, Raab, Marc S., Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor Wolfgang, Scheid, Christof, Weisel, Katja, Haenel, Mathias, Duerig, Jan, Goldschmidt, Hartmut
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Impact of cytogenetics at relapse on prognosis and benefit from salvage autologous stem cell transplantation in the GMMG phase III trial ReLApsE
Baertsch, Marc-A., Schlenzka, Jana, Hielscher, Thomas, Raab, Marc S., Hillengass, Jens, Müller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Hose, Dirk, Seckinger, Anja, Brossart, Peter, Goerner, Martin, Klein, Stefan, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans-Walter, Scheid, Christof, Nogai, Axel, Salwender, Hans J., Noppeney, Richard, Weisel, Katja, Goldschmidt, Hartmut
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival
Haas, Eva-Maria, Salwender, Hans J., Mai, Elias K., Dürig, Jan, Weisel, Katja, Tichy, Diana, Benner, Axel, Kunz, Christina, Hielscher, Thomas, Bertsch, Uta, Besemer, Britta, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Giessen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor Wolfgang, Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
TET2 Mutations In Acute Myeloid Leukemia (AML): Results on 783 Patients Treated within the AML HD98A Study of the AML Study Group (AMLSG)
Gaidzik, Verena I., Schlenk, Richard F., Paschka, Peter, Köhne, Claus-Henning, Held, Gerhard, Habdank, Marianne, Gohlke, Juliane, Mergenthaler, Hans-Günther, Salwender, Hans J., Bullinger, Lars, Döhner, Hartmut, Döhner, Konstanze
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article